+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Medicine Market - Global Forecast 2026-2032- Product Image
Veterinary Medicine Market - Global Forecast 2026-2032- Product Image
Sale

Veterinary Medicine Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5204994
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary Medicine Market is projected to reach USD 52.97 Billion in 2026. It is expected to continue growing at a CAGR of 8.13%, reaching USD 84.91 Billion by 2032.

Veterinary medicine for companion animals is shifting from episodic treatment to continuous, preventive, and data-informed care. Rising pet humanization, higher expectations for clinical quality, and broader adoption of diagnostics, nutrition, dentistry, dermatology, oncology, and chronic disease management are expanding the role of veterinary practices beyond acute care.

Verified industry indicators support this direction. The American Pet Products Association reports that roughly two-thirds of U.S. households own a pet, while veterinary associations in North America, Europe, and Asia-Pacific continue to highlight demand for preventive care, vaccination, parasite control, and geriatric pet services. Public health agencies also emphasize the One Health relevance of veterinary medicine through zoonotic disease prevention, antimicrobial stewardship, and responsible animal care.

Transformative Shifts in the Companion Animal Care Landscape

The companion animal care landscape is being reshaped by workforce shortages, consolidation of veterinary clinics, consumer-grade digital expectations, and the increasing complexity of pet health needs. Practices are investing in appointment automation, digital medical records, in-house diagnostics, and client communication platforms to improve throughput without compromising clinical standards.

Regulation and professional guidance remain central. Veterinary telemedicine rules vary by jurisdiction, particularly around the veterinarian-client-patient relationship, while antimicrobial stewardship, controlled substance management, pharmacovigilance, and animal welfare obligations continue to influence treatment decisions. These shifts are pushing practices to balance convenience, compliance, clinical evidence, affordability, and profitability.

Cumulative Impact of Artificial Intelligence in Companion Animal Care

Artificial intelligence is beginning to affect companion animal veterinary medicine through imaging support, triage tools, clinical documentation, appointment scheduling, inventory management, and client education. Peer-reviewed veterinary imaging studies have shown that machine learning can support pattern recognition in radiology, pathology, ophthalmology, and dermatology, but professional oversight remains essential because veterinary datasets vary by species, breed, age, device type, and clinical context.

The cumulative impact of AI is likely to be operational before it becomes fully autonomous clinically. Practices can use AI to reduce administrative burden, improve follow-up consistency, flag missed preventive care opportunities, support diagnostic prioritization, and strengthen evidence-based decision-making. However, governance is required around data privacy, model validation, explainability, bias mitigation, liability, cybersecurity, and the preservation of veterinarian-led care.

Key Regional Insights for Companion Animal Veterinary Medicine

Asia-Pacific is gaining importance in companion animal veterinary medicine as urbanization, rising disposable income, and growing pet ownership support demand for premium pet care in China, Japan, South Korea, India, and Australia. Regional veterinary demand is also shaped by rabies prevention, vaccination access, import controls, and expanding small animal clinical capacity. North America remains one of the most mature companion animal markets, supported by high pet ownership, advanced veterinary hospital networks, specialty practices, pet insurance adoption, and strong spending on diagnostics, wellness plans, dentistry, and preventive medicine.

Latin America is expanding through urban pet ownership and growing access to vaccines, parasiticides, and small animal practices, with Brazil and Mexico serving as important demand centers. Europe combines high clinical standards with stringent animal welfare and medicine regulations, including EU veterinary medicine rules that shape antimicrobial use, pharmacovigilance, and product oversight. The Middle East is investing in premium pet services in affluent urban centers, supported by expatriate pet ownership and rising animal welfare awareness. Africa shows a dual-market pattern: growing companion animal care in major cities alongside persistent gaps in access, vaccination coverage, disease surveillance, and veterinary workforce density.

Key Group Insights Across Companion Animal Markets

ASEAN markets are seeing rising demand for small animal clinics, pet nutrition, vaccination, and parasite prevention as urban pet ownership increases, particularly in Thailand, Vietnam, Indonesia, the Philippines, Malaysia, and Singapore. The GCC is developing premium companion animal services, specialty clinics, and regulated import pathways for veterinary products, supported by high-income consumer segments, urbanization, and growing awareness of animal welfare.

The European Union is influential through harmonized veterinary medicine rules, animal welfare policy, pharmacovigilance requirements, and antimicrobial stewardship, making compliance critical for market access. BRICS countries combine large pet populations with uneven clinical infrastructure, creating opportunities for scalable diagnostics, vaccines, digital workflow tools, and affordable care models. G7 markets lead in specialty medicine, pet insurance, diagnostics, clinical governance, and digital health adoption, while NATO countries overlap substantially with high-regulation veterinary systems where supply chain resilience, biosecurity, medicine availability, and disease preparedness are strategic priorities.

Key Country Insights for Companion Animal Veterinary Care

The United States leads in companion animal spending, specialty veterinary services, advanced diagnostics, and pet insurance growth, supported by high pet ownership and extensive hospital networks. Canada shows strong demand for preventive care, regulated veterinary pharmaceuticals, and companion animal wellness services, while Mexico is expanding urban companion animal services as access to clinics, vaccines, and parasite prevention improves. Brazil has one of the world’s large pet populations, making it a key market for vaccines, parasiticides, nutrition-linked veterinary care, and small animal clinical services.

The United Kingdom, Germany, France, Italy, and Spain are shaped by mature veterinary systems, companion animal ownership, specialty referrals, pet insurance penetration in selected markets, and EU or post-EU medicine governance. Russia remains a significant animal health market but faces supply chain and regulatory complexity. China is expanding rapidly in urban pet care, India combines rising companion animal ownership with affordability and access challenges, Japan is highly advanced in geriatric pet medicine as pets live longer, Australia emphasizes high clinical standards and biosecurity, and South Korea is growing through premium pet care, diagnostics, pet insurance interest, and digital client engagement.

Actionable Recommendations for Companion Animal Veterinary Leaders

Veterinary leaders should prioritize workflow redesign, preventive care compliance, and client communication before adding technology. High-impact investments include integrated practice management systems, AI-assisted documentation with clinician review, automated recall programs, diagnostic quality assurance, teletriage protocols, and transparent pricing models that improve adherence to recommended care.

Practices should also strengthen antimicrobial stewardship, controlled substance compliance, staff retention, mental health support, and continuing education. Suppliers and service providers can improve competitiveness by offering validated clinical tools, interoperability with veterinary records, cybersecurity controls, implementation support, and evidence-based outcomes that demonstrate time savings, diagnostic reliability, improved patient follow-up, or stronger preventive care compliance.

Research Methodology for Companion Animal Veterinary Analysis

This executive summary is based on secondary research from verified public and institutional sources, including veterinary medical associations, the World Organisation for Animal Health, the World Health Organization, the Food and Agriculture Organization, national veterinary regulators, the U.S. FDA Center for Veterinary Medicine, the European Medicines Agency, public animal health agencies, and peer-reviewed veterinary literature.

Insights were triangulated across pet ownership indicators, regulatory frameworks, veterinary workforce trends, animal health policy, antimicrobial stewardship guidance, zoonotic disease prevention priorities, and documented adoption of veterinary diagnostics, telehealth, and digital tools. Claims avoid unsupported market sizing, market share, and forecasting, focusing instead on evidence-backed directional trends relevant to veterinary medicine stakeholders.

Conclusion for Companion Animal Veterinary Medicine

Companion animal veterinary medicine is entering a more connected, preventive, and technology-enabled phase. Demand is supported by pet humanization, aging pets, expanding diagnostics, stronger preventive care expectations, and the need for accessible, high-quality clinical services.

The strongest opportunities will favor organizations that combine clinical evidence, operational efficiency, regulatory compliance, antimicrobial stewardship, and trusted client relationships. AI and digital platforms can improve productivity and continuity of care, but sustainable progress will depend on veterinarian-led governance, validated tools, privacy safeguards, and measurable improvements in patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Veterinary Medicine Market, by Product Type
7.1. Introduction
7.2. Pharmaceuticals
7.2.1. Antibiotics
7.2.2. Parasiticides
7.2.3. Immunomodulators
7.2.4. Antivirals
7.3. Vaccines
7.3.1. Inactivated
7.3.2. Live Attenuated
7.3.3. Recombinant
7.4. Biologics
7.4.1. Monoclonal
7.4.2. Cytokines
7.4.3. Growth Factors
8. Veterinary Medicine Market, by Animal Type
8.1. Introduction
8.2. Companion Animals
8.2.1. Cats
8.2.2. Dogs
8.2.3. Horses
8.2.4. Rabbits
8.3. Production Animals
8.3.1. Cattle
8.3.2. Poultry
8.3.3. Swine
8.3.4. Sheep
9. Veterinary Medicine Market, by Product Form
9.1. Introduction
9.2. Tablets
9.3. Capsules
9.4. Powders
9.5. Liquids
10. Veterinary Medicine Market, by Route Of Administration
10.1. Introduction
10.2. Inhalation
10.3. Injectable
10.4. Oral
10.5. Topical
11. Veterinary Medicine Market, by Disease Treatment
11.1. Introduction
11.2. Infectious Diseases
11.2.1. Bacterial Infections
11.2.2. Viral Infections
11.2.3. Fungal Infections
11.3. Parasitic Diseases
11.4. Metabolic Disorders
11.4.1. Diabetes
11.4.2. Obesity
11.4.3. Nutritional Deficiencies
11.5. Orthopedic Disorders
11.5.1. Arthritis
11.5.2. Fractures
11.5.3. Joint Dysplasia
11.6. Dermatological Conditions
11.6.1. Allergies
11.6.2. Skin Infections
11.7. Gastrointestinal Disorders
11.8. Cardiology
11.9. Neurology
12. Veterinary Medicine Market, by End User
12.1. Introduction
12.2. Veterinary Hospitals
12.3. Veterinary Clinics
12.4. Research Institutes
12.5. Pet Owners
12.6. Government & NGOs
13. Veterinary Medicine Market, by Distribution Channel
13.1. Introduction
13.2. Online
13.3. Offline
14. Veterinary Medicine Market, by Region
14.1. Asia-Pacific
14.2. North America
14.3. Latin America
14.4. Europe
14.5. Middle East
14.6. Africa
15. Veterinary Medicine Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Veterinary Medicine Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Archer-Daniels-Midland Company
18.2. Biogenesis Bago SA
18.3. Biopharm company
18.4. Biowet Pulawy sp. z o.o.
18.5. Brovapharma
18.6. C H Boehringer Sohn AG & Co KG
18.7. Ceva Sante Animale
18.8. Dechra Pharmaceuticals PLC
18.9. Elanco Animal Health Incorporated
18.10. Evonik Industries AG
18.11. Hester Biosciences Limited
18.12. Indian Immunologicals Ltd.
18.13. Intracin Pharmaceutical Private Limited
18.14. JoinHub Pharma
18.15. Merck & Co Inc.
18.16. Nam Pharma Sdn Bhd
18.17. NAPHAVET Co., Ltd.
18.18. Neogen Corporation
18.19. Nutreco NV
18.20. Phibro Animal Health Corporation
18.21. Sykes Vet International Pty Ltd.
18.22. TRAVETCO
18.23. Vetoquinol SA
18.24. Vetpharma Animal Health S.L.
18.25. Vetsintez LLC
18.26. Virbac SA
18.27. Weefsel Pharma
18.28. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL VETERINARY MEDICINE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL VETERINARY MEDICINE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL VETERINARY MEDICINE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL VETERINARY MEDICINE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL VETERINARY MEDICINE MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2025 VS 2032 (%)
FIGURE 11. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2025 VS 2032 (%)
FIGURE 15. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 19. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL VETERINARY MEDICINE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL VETERINARY MEDICINE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL VETERINARY MEDICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL VETERINARY MEDICINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL PARASITICIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL PARASITICIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL IMMUNOMODULATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL IMMUNOMODULATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL ANTIVIRALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL ANTIVIRALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL ANTIVIRALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL INACTIVATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL INACTIVATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL INACTIVATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL LIVE ATTENUATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL LIVE ATTENUATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL LIVE ATTENUATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL RECOMBINANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL RECOMBINANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL RECOMBINANT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL BIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL BIOLOGICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL MONOCLONAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL MONOCLONAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL MONOCLONAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL CYTOKINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL CYTOKINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL CYTOKINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL GROWTH FACTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL GROWTH FACTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL CATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL DOGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL DOGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL HORSES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL HORSES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL HORSES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL RABBITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL RABBITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL RABBITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL PRODUCTION ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL PRODUCTION ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL PRODUCTION ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL CATTLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL POULTRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL SWINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL SWINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL SHEEP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL SHEEP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL SHEEP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL TABLETS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL TABLETS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL TABLETS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL CAPSULES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL CAPSULES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL CAPSULES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL POWDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL POWDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL POWDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL LIQUIDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL LIQUIDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL LIQUIDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL INHALATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL INHALATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL INHALATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL PARASITIC DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL PARASITIC DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL PARASITIC DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL OBESITY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL OBESITY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL OBESITY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL NUTRITIONAL DEFICIENCIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL NUTRITIONAL DEFICIENCIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL NUTRITIONAL DEFICIENCIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL ARTHRITIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL ARTHRITIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL ARTHRITIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL FRACTURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL FRACTURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL FRACTURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL JOINT DYSPLASIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL JOINT DYSPLASIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL JOINT DYSPLASIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL DERMATOLOGICAL CONDITIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL DERMATOLOGICAL CONDITIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL DERMATOLOGICAL CONDITIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL ALLERGIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL ALLERGIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL ALLERGIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL SKIN INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL SKIN INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL SKIN INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 161. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL VETERINARY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 163. GLOBAL VETERINARY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 164. GLOBAL VETERINARY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 165. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 166. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 167. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 168. GLOBAL PET OWNERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 169. GLOBAL PET OWNERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 170. GLOBAL PET OWNERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 171. GLOBAL GOVERNMENT & NGOS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 172. GLOBAL GOVERNMENT & NGOS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 173. GLOBAL GOVERNMENT & NGOS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 174. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 175. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 176. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 177. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 178. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 179. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 180. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 181. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2017-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2017-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 199. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 200. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 201. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 202. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 203. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 204. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 205. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 206. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2017-2032 (USD MILLION)
TABLE 207. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 208. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 209. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 210. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 211. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 212. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 213. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2017-2032 (USD MILLION)
TABLE 214. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 215. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 216. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 217. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 218. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 219. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 220. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 221. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 222. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 223. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2017-2032 (USD MILLION)
TABLE 224. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 225. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 226. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 227. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 228. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 229. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 230. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2017-2032 (USD MILLION)
TABLE 231. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 232. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 233. EUROPE VETERINARY MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 234. EUROPE VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 235. EUROPE VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 236. EUROPE VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 237. EUROPE VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 238. EUROPE VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 239. EUROPE VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 240. EUROPE VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2017-2032 (USD MILLION)
TABLE 241. EUROPE VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 242. EUROPE VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 243. EUROPE VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 244. EUROPE VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 245. EUROPE VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 246. EUROPE VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 247. EUROPE VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2017-2032 (USD MILLION)
TABLE 248. EUROPE VETERINARY MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 249. EUROPE VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 250. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 251. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 252. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 253. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 254. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 255. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 256. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 257. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2017-2032 (USD MILLION)
TABLE 258. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 259. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 260. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 261. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 262. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 263. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 264. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2017-2032 (USD MILLION)
TABLE 265. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 266. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 267. AFRICA VETERINARY MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 268. AFRICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 269. AFRICA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 270. AFRICA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 271. AFRICA VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 272. AFRICA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 273. AFRICA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 274. AFRICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2017-2032 (USD MILLION)
TABLE 275. AFRICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 276. AFRICA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 277. AFRICA VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 278. AFRICA VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 279. AFRICA VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 280. AFRICA VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 281. AFRICA VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2017-2032 (USD MILLION)
TABLE 282. AFRICA VETERINARY MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 283. AFRICA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 284. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 285. ASEAN VETERINARY MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 286. ASEAN VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 287. ASEAN VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 288. ASEAN VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 289. ASEAN VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 290. ASEAN VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 291. ASEAN VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 292. ASEAN VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2017-2032 (USD MILLION)
TABLE 293. ASEAN VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 294. ASEAN VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 295. ASEAN VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 296. ASEAN VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 297. ASEAN VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 298. ASEAN VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 299. ASEAN VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2017-2032 (USD MILLION)
TABLE 300. ASEAN VETERINARY MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 301. ASEAN VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 302. GCC VETERINARY MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 303. GCC VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 304. GCC VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 305. GCC VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 306. GCC VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 307. GCC VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 308. GCC VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 309. GCC VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2017-2032 (USD MILLION)
TABLE 310. GCC VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 311. GCC VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 312. GCC VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 313. GCC VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 314. GCC VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 315. GCC VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 316. GCC VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2017-2032 (USD MILLION)
TABLE 317. GCC VETERINARY MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 318. GCC VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 319. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 320. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 321. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 322. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 323. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 324. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 325. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 326. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2017-2032 (USD MILLION)
TABLE 327. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 328. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 329. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 330. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 331. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 332. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 333. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2017-2032 (USD MILLION)
TABLE 334. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 335. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 336. BRICS VETERINARY MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 337. BRICS VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 338. BRICS VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 339. BRICS VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 340. BRICS VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 341. BRICS VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 342. BRICS VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 343. BRICS VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2017-2032 (USD MILLION)
TABLE 344. BRICS VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 345. BRICS VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 346. BRICS VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 347. BRICS VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 348. BRICS VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 349. BRICS VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 350. BRICS VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2017-2032 (USD MILLION)
TABLE 351. BRICS VETERINARY MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 352. BRICS VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 353. G7 VETERINARY MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 354. G7 VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 355. G7 VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2017-2032 (USD MILLION)
TABLE 356. G7 VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 357. G7 VETERINARY MEDICINE MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 358. G7 VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 359. G7 VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 360. G7 VETERINARY MEDICINE MARKET SIZE, BY PRODUCTION ANIMALS, 2017-2032 (USD MILLION)
TABLE 361. G7 VETERINARY MEDICINE MARKET SIZE, BY PRODUCT FORM, 2017-2032 (USD MILLION)
TABLE 362. G7 VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 363. G7 VETERINARY MEDICINE MARKET SIZE, BY DISEASE TREATMENT, 2017-2032 (USD MILLION)
TABLE 364. G7 VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 365. G7 VETERINARY MEDICINE MARKET SIZE, BY METABOLIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 366. G7 VETERINARY MEDICINE MARKET SIZE, BY ORTHOPEDIC DISORDERS, 2017-2032 (USD MILLION)
TABLE 367. G7 VETERINARY MEDICINE MARKET SIZE, BY DERMATOLOGICAL CONDITIONS, 2017-2032 (USD MILLION)
TABLE 368. G7 VETERINARY MEDICINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 369. G7 VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 370. NATO VETERINARY MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 371. NATO VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABL

Companies Mentioned

  • Archer-Daniels-Midland Company
  • Biogenesis Bago SA
  • Biopharm company
  • Biowet Puławy sp. z o.o.
  • Brovapharma
  • C H Boehringer Sohn AG & Co KG
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Evonik Industries AG
  • Hester Biosciences Limited
  • Indian Immunologicals Ltd.
  • Intracin Pharmaceutical Private Limited
  • JoinHub Pharma
  • Merck & Co Inc.
  • Nam Pharma Sdn Bhd
  • NAPHAVET Co., Ltd.
  • Neogen Corporation
  • Nutreco NV
  • Phibro Animal Health Corporation
  • Sykes Vet International Pty Ltd.
  • TRAVETCO
  • Vetoquinol SA
  • Vetpharma Animal Health S.L.
  • Vetsintez LLC
  • Virbac SA
  • Weefsel Pharma
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 52.97 Billion
Forecasted Market Value ( USD ) by 2032 $ 84.91 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Veterinary Therapeutics Market - Global Forecast 2026-2032 - Product Image

Veterinary Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Veterinary Drug Market - Global Forecast 2026-2032 - Product Image

Veterinary Drug Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Companion Animal Healthcare - Global Strategic Business Report - Product Image

Companion Animal Healthcare - Global Strategic Business Report

  • Report
  • 384 Pages
  • Global
From
Veterinary Diagnostics - Global Strategic Business Report - Product Image

Veterinary Diagnostics - Global Strategic Business Report

  • Report
  • 558 Pages
  • Global
From
Veterinary Medicine Market Report by Product, Animal Type, Route of Administration, Distribution Channel, and Region 2026-2034 - Product Image

Veterinary Medicine Market Report by Product, Animal Type, Route of Administration, Distribution Channel, and Region 2026-2034

  • Report
  • 139 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.